The Business Research Company's Osteoporosis Drugs Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033 You Can Now Pre Order Your Report To Get A Swift Deliver With ...

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...

Nonadherence to pharmacological treatment in osteoporosis is a well-recognized problem. As in other chronic diseases, adherence to osteoporosis treatment is poor, resulting in enormous burden on ...

Patients have told ABC NEWS they're concerned about a lack of informed consent over Australia's most common osteoporosis drug and are sometimes "scared into" taking it. Doctors acknowledge Prolia ...

Patients are raising concerns about a lack of informed consent over the nation's most popular osteoporosis drug. They say not enough of them are being adequately informed of side effects or ...

According to Indian Menopause Society, around 50 million women in India are affected by osteoporosis, with the risk significantly increasing post-menopause. The menopausal syndrome often manifests ...

They say not enough of them are being adequately informed of side effects or complications when coming-off the drug. Patients are raising concerns about a lack of informed consent over the nation ...

July 24, 2024 — Surgeons compared traditional and new fully hydroxyapatite-coated hip replacement stems. They found the new stems offer larger contact areas, while traditional ones preserve bone ...

Commonly used calcium supplement Shelcal 500 and antacid Pan D are among the four drugs flagged as spurious by the Central ...